Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CD20 Recombinant Antibody(Ublituximab)

Anti-Human CD20 Recombinant Antibody(Ublituximab)

Product Number

YR1251

Alias

科研级 Ublituximab ( 乌妥昔单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ublituximab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Ublituximab ( 乌妥昔单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ublituximab
Catalog NumberYR1251
Molecular NameUblituximab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundUblituximab is an immunomodulator. It binds to CD20. It is in Phase 3 clinical trials for multiple sclerosis. It is also in "U2" Phase 3 clinical trials for chronic lymphocytic leukemia in combination with Umbralisib.
CAS Number1174014-05-1
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD20[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now